KG Co Gmbh Vi Fund Venture Atlas Net Worth & Insider Trades

KG Co Gmbh Vi Fund Venture Atlas Horizon Pharma, Inc

As of March 6, 2012

What is KG Co Gmbh Vi Fund Venture Atlas's Net Worth?

The current estimated net worth of Horizon Pharma, Inc's KG Co Gmbh Vi Fund Venture Atlas is estimated to be about $252.6M . KG Co Gmbh Vi Fund Venture Atlas owns about 3,688,294 units of Horizon Pharma, Inc common stock. In the last year at Horizon Pharma, Inc, KG Co Gmbh Vi Fund Venture Atlas has sold an estimated value of $0 worth.

What is KG Co Gmbh Vi Fund Venture Atlas's Past Insider Trading?

KG Co Gmbh Vi Fund Venture Atlas's largest purchase order was 2,533,327 units , worth over $6.98M on August 4, 2011. In total, KG Co Gmbh Vi Fund Venture Atlas has made about 2 transactions over a year of their time at Horizon Pharma, Inc. KG Co Gmbh Vi Fund Venture Atlas usually trades in August and March, with the busiest year in 2011 and 2012. The most recent transaction was a purchase order of 828,443 units , worth over $3M on March 6, 2012.

ATLAS VENTURE FUND VI LP, KG Co GmbH VI Fund Venture Atlas, Atlas Venture Associates VI LP, ATLAS VENTURE ENTREPRENEURS FUND VI LP

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is KG Co Gmbh Vi Fund Venture Atlas's' Mailing Address?

  • Mailing address is 890 Winter Street Suite 320 Waltham MA 02451 MA

Horizon Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Timothy P. Walbert 2020 $1,146,542 - $199,548 $199,548 $199,548 $199,548 $21,632,803
Timothy P. Walbert 2019 $1,108,700 - $226,871 $226,871 $226,871 $226,871 $13,873,172
Timothy P. Walbert 2018 $1,076,250 - $160,363 $160,363 $160,363 $160,363 $16,796,894
Paul W. Hoelscher 2020 $600,569 - $106,485 $106,485 $106,485 $106,485 $5,915,146
Paul W. Hoelscher 2019 $580,748 - $120,135 $120,135 $120,135 $120,135 $4,443,588
Paul W. Hoelscher 2018 $563,750 - $104,332 $104,332 $104,332 $104,332 $7,034,386
Andy Pasternak 2020 $669,021 $250,000 $66,872 $66,872 $66,872 $66,872 $5,826,126
Andy Pasternak 2019 $108,333 $500,000 $19,188 $19,188 $19,188 $19,188 $2,924,542
Jeffrey W. Sherman, M.D., FACP 2020 $578,731 - $92,545 $92,545 $92,545 $92,545 $5,261,300
Jeffrey W. Sherman, M.D., FACP 2019 $559,630 - $95,222 $95,222 $95,222 $95,222 $3,568,496
Jeffrey W. Sherman, M.D., FACP 2018 $543,250 - $68,263 $68,263 $68,263 $68,263 $3,678,874
Barry J. Moze 2020 $628,960 - $75,659 $75,659 $75,659 $75,659 $5,073,877
Barry J. Moze 2019 $608,201 - $58,744 $58,744 $58,744 $58,744 $4,662,510
Barry J. Moze 2018 $590,400 - $35,114 $35,114 $35,114 $35,114 $2,732,565
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm

What are Horizon Pharma, Inc's Past Insider Trades?

Horizon Pharma, Inc's most recent insider trade came on August 8, 2022 by Sean Clayton who bought 745 units worth $49.67K . In the last 11 years, insiders at Horizon Pharma, Inc have sold an estimated value of $682.77M and bought an estimated value of $119.53M worth of shares. Insider trading is most common in January and May, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman,  Jeffrey Sherman, EVP and Chief Medical Officer,  and Paul Hoelscher, EVP .

Horizon Therapeutics Public Ltd Co Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1